Close X
Wednesday, November 27, 2024
ADVT 
National

Cdn economy to resume growth in 2024: report

Darpan News Desk The Canadian Press, 28 Sep, 2023 10:36 AM
  • Cdn economy to resume growth in 2024: report

Canadian economy to get 'back on its feet' next year, Deloitte Canada says. 

A new report from Deloitte Canada suggests the economy's near-term struggles will ease next year as the Bank of Canada begins cutting its key lending rate.

The report estimates GDP will rise one per cent this year and 0.9 per cent next year. Deloitte Canada had earlier predicted GDP would contract 0.9 per cent in 2023.

It says a population surge in Canada and an improved outlook for trade with the U.S. likely prevented the country from going into a deeper recession.

The report predicts the Bank of Canada will start lowering interest rates next spring, eventually bringing the overnight rate to three per cent by mid-2025.

MORE National ARTICLES

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland
Newly appointed Health Minister Mark Holland says he doesn't want to go waving a stick around as he negotiates the final details of a health accord with provinces and territories, and it'll largely be up to Canadians to hold them accountable. All provinces except Quebec accepted the $198-billion deal in principle earlier this year and are expected to sign final agreements before the end of 2023.

Ottawa 'shouldn't walk around with a stick' to enforce health deals: Holland

PharmaCare covers medicine to treat rare diseases

PharmaCare covers medicine to treat rare diseases
The province says its PharmaCare program now covers medications used to treat rare diseases such as A-L-S. The Ministry of Health says the oral form of edaravone, which is used to treat A-L-S patients, will be added to the PharmaCare formulary as a limited-coverage benefit.

PharmaCare covers medicine to treat rare diseases

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer
A shortage of diabetes drug Ozempic that is used off-label for weight loss is expected in Canada, the manufacturer says. Health Canada says intermittent shortages are expected from late August to early October.  

Shortage of diabetes and weight loss drug Ozempic expected in Canada: manufacturer

Feds could spur rental construction with tax incentives, financing: experts

Feds could spur rental construction with tax incentives, financing: experts
Strong demand for rentals and a shortage of homes are both contributing to soaring rental costs. And that's making it even more difficult for people to save money for down payment on a home. For most minimum-wage workers, affording these rents with their earnings is impossible. 

Feds could spur rental construction with tax incentives, financing: experts

Home prices in Canada continue to rise

Home prices in Canada continue to rise
Home prices in Canada continued to rise last month, the fourth consecutive monthly increase. Eight of the 11 markets in the composite index were up in July led by Halifax at 4.9 per cent, Vancouver at 3.9 per cent and Toronto at 3.5 per cent.

Home prices in Canada continue to rise

West Kelowna evacuations triple, as City of Kelowna declares wildfire emergency

West Kelowna evacuations triple, as City of Kelowna declares wildfire emergency
The "very active and unpredictable" McDougall Creek wildfire has grown more than six times during a frightening night, destroying homes and putting more than 2,400 West Kelowna properties under evacuation order, up from about 800 Thursday afternoon.  

West Kelowna evacuations triple, as City of Kelowna declares wildfire emergency